GeneOne Life Science, Inc. announced that it has received KRW 2.95000061 billion in funding

GeneOneLifeScience, formerly VGX International, Inc., is a Korea-based company engaged in textile and biopharmaceutical businesses. The Company is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. It also engaged in the leasing of nonresidential buildings.